Global Silymarin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Silymarin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Silymarin market size was valued at US$ 95.8 million in 2024 and is forecast to a readjusted size of USD 119 million by 2031 with a CAGR of 3.1% during review period.

Silymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.

The top players cover LIVERD PHARMA, TY Pharmaceutical, KEB Biotech, etc. The Top 3 players in Global Silymarin market revenue was 50.46% in 2019, while the share of top 5 players was 61.99%. TY Pharmaceutical is the leading supplier of Silymarin, the production of which reached 438 MT in 2019, accounting for about 18.81% of the Global market. Market concentration is high. Except policy affect, downstream demand is the key influence factor to the market.

This report is a detailed and comprehensive analysis for global Silymarin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Silymarin market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031

Global Silymarin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031

Global Silymarin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031

Global Silymarin market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Silymarin

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Silymarin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include LIVERD PHARMA, Huacheng Pharmaceutical, TY Pharmaceutical, Teva API, KEB Biotech, Shengbo Silymarin, Panjin Fengrui, Jiaherb, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Silymarin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Silymarin Extracted by Acetone
Silymarin Extracted by Ethyl Acetate
Silymarin Extracted by Ethanol
Water Soluble Silymarin

Market segment by Application
Pharma and Healthcare
Food Additives
Cosmetic and Skin Care
Others

Major players covered
LIVERD PHARMA
Huacheng Pharmaceutical
TY Pharmaceutical
Teva API
KEB Biotech
Shengbo Silymarin
Panjin Fengrui
Jiaherb

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Silymarin product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Silymarin, with price, sales quantity, revenue, and global market share of Silymarin from 2020 to 2025.

Chapter 3, the Silymarin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Silymarin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Silymarin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Silymarin.

Chapter 14 and 15, to describe Silymarin sales channel, distributors, customers, research findings and conclusion.